| RSI Alert For Top-Ranked Teva Pharmaceutical Industries (EN, Forbes) |
| Analyst Moves: SFD, TEVA (EN, Forbes) |
| Pharmaindustrie: Generikariese Teva senkt Prognosen (Handelsblatt) |
| Teva Cuts Revenue Forecast for Year (EN, Benzinga earnings) |
| Teva Rising Despite Guidance Cuts (EN, The Wall Street Journal Deutschland) |
| Teva Rising Despite Guidance Cuts (EN, Barrons) |
| Teva: Prognose für das laufende Fiskaljahr konkretisiert (Aktiencheck) |
| Teva outlines financial estimates for 2012 (EN, Market Watch) |
| Daily Dividend Report: COF, MMM, TEVA, CSX, SCI (EN, Forbes) |
| Teva Pharmaceutical Industries Beats Analyst Estimates on EPS (EN, MotleyFool) |
| Teva Pharma 1Q profit climbs 13 percent (EN, Yahoo) |
| Teva: Erwartungen im ersten Quartal übertroffen, Rücktritt von CEO (Aktiencheck) |
| Generikahersteller : US-Geschäft bringt Teva Gewinnsprung (Handelsblatt) |
| UPDATE: Teva Posts Upbeat Q1 Profit, Declares Dividend (EN, Benzinga earnings) |
| Generikakonzern Teva mit kräftigem Gewinnplus - Umsatzanstieg enttäuscht Markt (dpa-afx) |
| Teva 1st-quarter net up 13%, revenue up 25% (EN, Market Watch) |
| Teva Is Easy Pill to Swallow (EN, Wall Street Journal) |
| Teva Is Easy Pill to Swallow (EN, The Wall Street Journal Deutschland) |
| Something to Watch With Teva (EN, MotleyFool) |
| Making a Case for Teva Pharmaceutical Industries (EN, MotleyFool) |
| Is Teva About to Tear Itself Apart? (EN, MotleyFool) |
| Will Teva Pharmaceutical Help You Retire Rich? (EN, MotleyFool) |
| Teva Canada Announces Sale of Mirabel (Quebec) Facility to HaloPharmaceutical (EN, CNX) |
| NYSE Scores Teva Listing From Nasdaq (EN, The Wall Street Journal Deutschland) |
| Teva-Pharmaceutical: Generikahersteller wechselt an die NYSE (Aktiencheck) |
| Teva to Switch Listing to NYSE in May (EN, Wall Street Journal) |
| How Teva Pharmaceutical Industries Is Bringing Bucks Home More Quickly (EN, MotleyFool) |
| Did Teva Pharmaceutical Industries Squander Its Latest Sales Increase? (EN, MotleyFool) |
| A Hidden Reason Teva Pharmaceutical Industries' Future Looks Bright (EN, MotleyFool) |
| 5-Star Stocks Poised to Pop: Teva Pharmaceutical (EN, MotleyFool) |
| Teva Pharmaceutical: Dividend Dynamo or the Next Blowup? (EN, MotleyFool) |
| A Leap of Faith: Teva Pharmaceutical (EN, MotleyFool) |
| Here's How Teva Pharmaceutical Is Making You So Much Cash (EN, MotleyFool) |
| Teva Pharmaceutical Industries Passes This Key Test (EN, MotleyFool) |
| $5 Billion Hedge Fund Sells Apple, Adds Cigna and Teva (EN, MotleyFool) |
| Teva Said to Pay $250 Million to End Nevada Propofol Cases (EN, Business Week) |
| Teva Pharmaceutical Industries Limited's Latest EPS Top Last Year's by 39% (EN, MotleyFool) |
| Profits Down, Dividends Up at Teva Pharmaceuticals (EN, MotleyFool) |
| Teva reported solid Q4 results, says Wells Fargo (EN, Yahoo) |
| Ratiopharm-Mutter: Zukäufe von Teva zahlen sich aus (Handelsblatt) |